GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » RP Bio lnc (XKRX:314140) » Definitions » Change In Payables And Accrued Expense

RP Bio lnc (XKRX:314140) Change In Payables And Accrued Expense : ₩0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is RP Bio lnc Change In Payables And Accrued Expense?

RP Bio lnc's Change In Payables And Accrued Expense for the quarter that ended in Sep. 2024 was ₩0 Mil. It means RP Bio lnc's Accounts Payable & Accrued Expense stayed the same from Jun. 2024 to Sep. 2024 .

RP Bio lnc's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was ₩0 Mil. It means RP Bio lnc's Accounts Payable & Accrued Expense stayed the same from Dec. 2022 to Dec. 2023 .


RP Bio lnc Change In Payables And Accrued Expense Historical Data

The historical data trend for RP Bio lnc's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RP Bio lnc Change In Payables And Accrued Expense Chart

RP Bio lnc Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Change In Payables And Accrued Expense
- - - - -

RP Bio lnc Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Change In Payables And Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

RP Bio lnc Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


RP Bio lnc Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of RP Bio lnc's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


RP Bio lnc Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » RP Bio lnc (XKRX:314140) » Definitions » Change In Payables And Accrued Expense
Traded in Other Exchanges
N/A
Address
634, Samseong-ro, Gangnam-gu, Seoul, KOR, 06084
RP Bio lnc is engaged in the pharmaceutical manufacturing business. It produces softgels, finished drugs, and other products.

RP Bio lnc Headlines

No Headlines